The heterogeneity in clinical phenotypes that ranged from motor neuron disease to FTD and the variation in time of symptom onset within and between families of C9orf72 mutation carriers may be responsible for the variable results from cross-sectional DTI investigations in asymptomatic C9orf72 mutation carriers. This evidence concerns the gene C9orf72 and frontotemporal dementia.